[1] |
Watkins WM, Mosobo M.Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life[J]. Trans R Soc Trop Med Hyg, 1993, 87(1): 75-78.
|
[2] |
潘梅, 陆艳. 磺胺多辛乙胺嘧啶片微生物限度检查方法的建立[J]. 生命科学仪器, 2008, 6(5): 45-47.
|
[3] |
Compaoré R, Yameogo MWE, Millogo T, et al. Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso[J]. PLoS One, 2017, 12(11): e0187460.
|
[4] |
Ntirushwa D.A strategic framework for malaria prevention and control during pregnancy in the African region[Z]. Geneva: World Health Organization, 2004.
|
[5] |
Hernandez T, Myatt AV, Coatney GR, et al. Studies in human malaria. XXXIV. acquired resistance to pyrimethamine (daraprim) by the shesson strain of Plasmodium vivax[J]. Am J Trop Med Hyg, 1953, 2(5): 797-804.
|
[6] |
Young MD, Burgess RW.Pyrimethamine resistance in Plasmodium vivax malaria[J]. Bull World Health Organ, 1959, 20(1): 27-36.
|
[7] |
Walker PG, Floyd J, Ter Kuile F, et al. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: a mathematical model[J]. PLoS Med, 2017, 14(2): e1002243.
|
[8] |
de Oliveira TC, Rodrigues PT, Menezes MJ, et al. Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax[J]. PLoS Negl Trop Dis, 2017, 11(7): e0005824.
|
[9] |
Saralamba N, Nakeesathit S, Mayxay M, et al. Geographic distribution of amino acid mutations in DHFR and DHPS in Plasmodium vivax isolates from Lao PDR, India and Colombia[J]. Malar J, 2016, 15(1): 484.
|
[10] |
Ndiaye YD, Diédhiou CK, Bei AK, et al. High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations[J]. Malar J, 2017, 16: 153.
|
[11] |
Vinayak S, Alam MT, Mixson-Hayden T, et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum[J]. PLoS Pathog, 2010, 6(3): e1000830.
|
[12] |
Barnadas C, Tichit M, Bouchier C, et al. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine[J]. Malar J, 2008, 7: 35.
|
[13] |
Asih PB, Marantina SS, Nababan R, et al. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia[J]. Malar J, 2015, 14: 365.
|
[14] |
Triglia T, Wang P, Sims PF, et al. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria[J]. EMBO J, 1998, 17(14): 3807-3815.
|
[15] |
Maghsoodloorad S, Haghighi A, Sharifi Sarasiabi K, et al. Genetic diversity of dihydropteroate synthetase gene (dhps) of Plasmodium vivax in Hormozgan Province, Iran[J]. Iran J Parasitol, 2016, 11(1): 98-103.
|
[16] |
Das S, Banik A, Hati AK, et al. Low prevalence of dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) quadruple and quintuple mutant alleles associated with SP resistance in Plasmodium vivax isolates of West Bengal, India[J]. Malar J, 2016, 15(1): 395.
|
[17] |
Ganguly S, Saha P, Chatterjee M, et al. Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India[J]. Antimicrob Agents Chemother, 2013, 58(1): 196-200.
|
[18] |
Raza A, Ghanchi NK, Khan MS, et al. Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan[J]. Malar J, 2013, 12: 261.
|
[19] |
车立刚, 张有林, 李兴亮, 等. 云南勐腊县恶性疟原虫对复方乙胺嘧啶敏感性观察[J]. 中国寄生虫病防治杂志, 1992, 5(3): 217.
|
[20] |
车立刚, 张有林, 李兴亮, 等. 控制抗药性恶性疟暴发的现场研究[J]. 中国公共卫生学报, 1993, (5): 288.
|
[21] |
杨恒林, 杨品芳, 杨亚明, 等. 云南南部恶性疟原虫对甲氟喹、奎宁、氨酚喹、氯喹、磺胺多辛/乙胺嘧啶及咯萘啶敏感性的体外测定[J]. 中国寄生虫学与寄生虫病杂志, 1994, 12(2): 140-142.
|
[22] |
Koepfli C, Rodrigues PT, Antao T, et al. Plasmodium vivax diversity and population structure across four continents[J]. PLoS Negl Trop Dis, 2015, 9(6): e0003872.
|
[23] |
Hupalo DN, Luo Z, Melnikov A, et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax[J]. Nat Genet, 2016, 48(8): 953-958.
|
[24] |
Lo E, Hemming-Schroeder E, Yewhalaw D, et al. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes[J]. PLoS Negl Trop Dis, 2017, 11(7): e0005806.
|
[25] |
董莹, 毛祥华, 陈梦妮, 等. 2012-2014年云南省疟疾实验室诊断质量分析[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(3): 191-195.
|
[26] |
董莹, 孙艾明, 陈梦妮, 等. 云南省输入性及本地感染间日疟原虫裂殖子表面蛋白1基因5区序列的多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(1): 1-7.
|
[27] |
Ding S, Ye R, Zhang D, et al. Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivax[J]. Sci Rep, 2013, 3: 1008.
|
[28] |
Korsinczky M, Fischer K, Chen N, et al. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site[J]. Antimicrob Agents Chemother, 2004, 48(6): 2214-2222.
|
[29] |
Barnadas C, Senn N, Iga J, et al. Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea[J]. Antimicrob Agents Chemother, 2014, 58(11): 6958-6961.
|
[30] |
Huang F, Zhou S, Zhang S, et al. Monitoring resistance of Plasmdium vivax: point mutations in dihydrofolate reductase gene in isolates from Central China[J]. Parasit Vectors, 2011, 4: 80.
|
[31] |
Mohapatra PK, Prakash A, Taison K, et al. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas[J]. Trop Med Int Health, 2005, 10(5): 478-483.
|
[32] |
Mishra N, Kaitholia K, Srivastava B, et al. Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India[J]. Malar J, 2014, 13: 284.
|
[33] |
White NJ.Determinants of relapse periodicity in Plasmodium vivax malaria[J]. Malar J, 2011, 10: 297.
|
[34] |
董莹, 孙艾明, 邓艳, 等. 云南省恶性疟原虫氯喹及青蒿素抗性相关基因的联合突变分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(3): 202-208.
|
[35] |
朱垚吉, 陈梦妮, 徐艳春, 等. 云南省恶性疟原虫Pfcrt基因exon2区72~76编码序列多态性的分析[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(3): 227-232, 234.
|
[36] |
孙艾明, 董莹, 陈梦妮, 等. 云南省恶性疟原虫青蒿素耐药性相关基因K13 kelch结构域序列多态性的分析[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(4): 339-345.
|